The recovery process for patients with acute spinal cord injuries can be enhanced by antibodies. This has been studied with encouraging results by researchers at 13 clinics in Germany, Switzerland, the Czech Republic, and Spain. For the first time, patient groups exhibiting a treatment impact that was clinically relevant could be identified. December 2024 will see the start of a follow-up study.

Skip to content